Angiotensin II type 2 receptor signalling as a pain target: Bench, bedside and back-translation.

Shepherd, Andrew J; Rice, Andrew Sc; Smith, Maree T

Shepherd, Andrew J; Rice, Andrew Sc; Smith, Maree T.

Afiliação

Shepherd AJ; The MD Anderson Pain Research Consortium and the Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rice AS; Pain Research, Department of Surgery & Cancer, Imperial College London, London, UK.
Smith MT; School of Biomedical Sciences, The University of Queensland, St Lucia Campus, Brisbane, Queensland, Australia. Electronic address: maree.smith@uq.edu.au.

Curr Opin Pharmacol ; 73: 102415, 2023 Dec.

Article em En | MEDLINE | ID: mdl-38041933

Assuntos

Neuralgia; Receptor Tipo 2 de Angiotensina; Humanos; Bloqueadores do Receptor Tipo 2 de Angiotensina II/farmacocinética; Neuralgia/tratamento farmacológico; Compostos Benzidrílicos/farmacologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor Tipo 2 de Angiotensina / Neuralgia Limite: Humans Idioma: En Revista: Curr Opin Pharmacol Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google